Skip to content
Home/Companies/Biotech/Doccla
DO

Doccla

Biotech·UK·Active·2yr hold

Doccla is a life sciences company, headquartered in United Kingdom.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns Doccla?

Doccla is currently owned by Elaia Partners through Elaia DV5 (2026 vintage), since 2024.

Hand-verified · updated 2026-04-21

Elaia Partners
Investor
Elaia Partners
Elaia DV5 · 2026 · VC

Key facts

HQUnited Kingdom
SectorLife Sciences

More from Elaia DV5

Other portfolio companies in the same fund.

Linkup
Active
SoftwareUS· 2026
Descartes&Mauss
Active
Data & AnalyticsFrance· 2024
Mitiga Solutions
Active
ClimateTechSpain· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings